The Impact of the COVID-19 Pandemic on Mental Health Care of Children and Adolescents in Switzerland: Results of a Survey among Mental Health Care Professionals after One Year of COVID-19.

COVID-19 adolescents child and adolescent psychiatry children mental health care telemental health treatment supply

Journal

International journal of environmental research and public health
ISSN: 1660-4601
Titre abrégé: Int J Environ Res Public Health
Pays: Switzerland
ID NLM: 101238455

Informations de publication

Date de publication:
10 03 2022
Historique:
received: 11 01 2022
revised: 03 03 2022
accepted: 07 03 2022
entrez: 25 3 2022
pubmed: 26 3 2022
medline: 1 4 2022
Statut: epublish

Résumé

To assess the impact of the COVID-19 pandemic on treatment demand and supply in children and adolescents with mental disorders during the first year of the pandemic from the perspective of child and adolescent psychiatrists and psychologists in Switzerland. The survey was conducted anonymously, in German or French and online in April/May 2021. Mental health professionals working in child and adolescent psychiatry, psychotherapy services or independent practices were contacted by email. N = 454 professionals completed the survey (176 child and adolescent psychiatrists and 276 psychologists). After an initial period of decreased demand during the lockdown in spring 2020, requests for treatment increased, considerably exceeding the demand pre-pandemic and reaching a peak in January/February/March 2021. The vast majority of professionals (78.2%) estimated that there was currently too little supply during the pandemic, which differed from the evaluation of the pre-pandemic situation (37%). A total of 65% of participants indicated that waiting time until the initiation of treatment increased during the pandemic, 41% reported their current workload to be somewhat higher and 44.5% much higher. For the first pandemic year, youth mental health professionals reported a large increase in the treatment demand and waiting time and a worrisome overload of treatment services.

Sections du résumé

BACKGROUND
To assess the impact of the COVID-19 pandemic on treatment demand and supply in children and adolescents with mental disorders during the first year of the pandemic from the perspective of child and adolescent psychiatrists and psychologists in Switzerland.
METHODS
The survey was conducted anonymously, in German or French and online in April/May 2021. Mental health professionals working in child and adolescent psychiatry, psychotherapy services or independent practices were contacted by email.
RESULTS
N = 454 professionals completed the survey (176 child and adolescent psychiatrists and 276 psychologists). After an initial period of decreased demand during the lockdown in spring 2020, requests for treatment increased, considerably exceeding the demand pre-pandemic and reaching a peak in January/February/March 2021. The vast majority of professionals (78.2%) estimated that there was currently too little supply during the pandemic, which differed from the evaluation of the pre-pandemic situation (37%). A total of 65% of participants indicated that waiting time until the initiation of treatment increased during the pandemic, 41% reported their current workload to be somewhat higher and 44.5% much higher.
CONCLUSIONS
For the first pandemic year, youth mental health professionals reported a large increase in the treatment demand and waiting time and a worrisome overload of treatment services.

Identifiants

pubmed: 35328941
pii: ijerph19063252
doi: 10.3390/ijerph19063252
pmc: PMC8953578
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Références

Swiss Med Wkly. 2022 Feb 23;152:
pubmed: 35230030
Curr Psychiatry Rep. 2021 Oct 6;23(11):75
pubmed: 34613515
Pediatrics. 2021 Sep;148(3):
pubmed: 34140393
Compr Psychiatry. 2021 Aug;109:152260
pubmed: 34265597
J Psychiatr Res. 2022 Mar;147:313-323
pubmed: 35124401
Lancet Child Adolesc Health. 2020 Jun;4(6):421
pubmed: 32302537
PLoS One. 2021 Sep 16;16(9):e0257270
pubmed: 34529705
Neuropsychiatr Enfance Adolesc. 2021 May;69(3):121-131
pubmed: 33727757
Int J Environ Res Public Health. 2021 Apr 22;18(9):
pubmed: 33922281
Int J Environ Res Public Health. 2021 Mar 26;18(7):
pubmed: 33810225
Child Youth Care Forum. 2021 Jul 19;:1-14
pubmed: 34305371
Eur Child Adolesc Psychiatry. 2021 Jul 10;:
pubmed: 34247297
Child Adolesc Psychiatry Ment Health. 2021 Jun 21;15(1):32
pubmed: 34154612
BJPsych Open. 2021 May 03;7(3):e91
pubmed: 33938419
Early Interv Psychiatry. 2021 Jul 26;:
pubmed: 34309196
JAMA Pediatr. 2021 Nov 1;175(11):1142-1150
pubmed: 34369987
Australas Psychiatry. 2021 Dec;29(6):628-634
pubmed: 34428987
Int J Environ Res Public Health. 2021 Apr 27;18(9):
pubmed: 33925743
J Health Serv Psychol. 2020 Nov 15;:1-10
pubmed: 33225314
Clin Child Psychol Psychiatry. 2022 Jan;27(1):112-121
pubmed: 34229484
Eur Child Adolesc Psychiatry. 2021 Jul 29;:
pubmed: 34322720
Pediatrics. 2021 Mar;147(3):
pubmed: 33328339
Asian J Psychiatr. 2020 Dec;54:102300
pubmed: 32683251
Int J Environ Res Public Health. 2021 Sep 13;18(18):
pubmed: 34574547

Auteurs

Anna Maria Werling (AM)

Department of Child and Adolescent Psychiatry and Psychotherapy, University Hospital of Psychiatry Zurich, University of Zurich, 8032 Zurich, Switzerland.

Susanne Walitza (S)

Department of Child and Adolescent Psychiatry and Psychotherapy, University Hospital of Psychiatry Zurich, University of Zurich, 8032 Zurich, Switzerland.
Swiss Society for Child and Adolescent Psychiatry and Psychotherapy, 3008 Bern, Switzerland.
Neuroscience Center Zurich, University of Zurich and ETH Zurich, 8057 Zurich, Switzerland.

Stephan Eliez (S)

Swiss Society for Child and Adolescent Psychiatry and Psychotherapy, 3008 Bern, Switzerland.
Department of Psychiatry, Faculty of Medicine, University of Geneva, 1205 Geneva, Switzerland.

Renate Drechsler (R)

Department of Child and Adolescent Psychiatry and Psychotherapy, University Hospital of Psychiatry Zurich, University of Zurich, 8032 Zurich, Switzerland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH